Contributions of adipocyte lipid metabolism to body fat content and implications for the treatment of obesity

Current Opinion in Pharmacology

Volumn 10, Issue 5, 2010, Pages 588-593

  Marcelin, Genevieve ^a   Chua, Streamson ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOSPORIN; FAT DROPLET; FATTY ACID; GROWTH HORMONE; INSULIN; LEPTIN; RAPAMYCIN; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 1;

ADIPOCYTE; BODY FAT; BODY MASS; BROWN ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CELL MATURATION; DRUG SYNTHESIS; ENERGY BALANCE; ENERGY METABOLISM; FAT CONTENT; FATTY ACID OXIDATION; HUMAN; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; MALIGNANT NEOPLASTIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TISSUE DIFFERENTIATION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; HUMANS; LIPID METABOLISM; MICE; MODELS, ANIMAL; OBESITY; OXIDATION-REDUCTION; TRIGLYCERIDES;

EID: 77956647929     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2010.05.008     Document Type: Review

References (54)

1. Hofbauer K.G. Molecular pathways to obesity. Int J Obes Relat Metab Disord 2002, 26(Suppl. 2):S18-S27.
2. Seale P., Kajimura S., Spiegelman B.M. Transcriptional control of brown adipocyte development and physiological function-of mice and men. Genes Dev 2009, 23:788-797.
3. Levin N., Nelson C., Gurney A., Vandlen R., de Sauvage F. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci U S A 1996, 93:1726-1730.
4. Weiss E.P., Racette S.B., Villareal D.T., Fontana L., Steger-May K., Schechtman K.B., Klein S., Ehsani A.A., Holloszy J.O. Lower extremity muscle size and strength and aerobic capacity decrease with caloric restriction but not with exercise-induced weight loss. J Appl Physiol 2007, 102:634-640.
5. Levak-Frank S., Radner H., Walsh A., Stollberger R., Knipping G., Hoefler G., Sattler W., Weinstock P.H., Breslow J.L., Zechner R. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J Clin Invest 1995, 96:976-986.
6. Yagyu H., Chen G., Yokoyama M., Hirata K., Augustus A., Kako Y., Seo T., Hu Y., Lutz E.P., Merkel M., et al. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 2003, 111:419-426.
7. Jaworski K., Ahmadian M., Duncan R.E., Sarkadi-Nagy E., Varady K.A., Hellerstein M.K., Lee H.Y., Samuel V.T., Shulman G.I., Kim K.H., et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med 2009, 15:159-168.
8. Guerra C., Koza R.A., Yamashita H., Walsh K., Kozak L.P. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest 1998, 102:412-420.
9. Lafontan M., Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 2009, 48:275-297.
10. Buettner C., Muse E.D., Cheng A., Chen L., Scherer T., Pocai A., Su K., Cheng B., Li X., Harvey-White J., et al. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat Med 2008, 14:667-675.
11. Choi Y.H., Park S., Hockman S., Zmuda-Trzebiatowska E., Svennelid F., Haluzik M., Gavrilova O., Ahmad F., Pepin L., Napolitano M., et al. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice. J Clin Invest 2006, 116:3240-3251.
12. Duncan R.E., Ahmadian M., Jaworski K., Sarkadi-Nagy E., Sul H.S. Regulation of lipolysis in adipocytes. Annu Rev Nutr 2007, 27:79-101.
13. Ahmed K., Tunaru S., Tang C., Muller M., Gille A., Sassmann A., Hanson J., Offermanns S. An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell Metab 2010, 11:311-319.
14. Nogueiras R., Wiedmer P., Perez-Tilve D., Veyrat-Durebex C., Keogh J.M., Sutton G.M., Pfluger P.T., Castaneda T.R., Neschen S., Hofmann S.M., et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 2007, 117:3475-3488.
15. Brito M.N., Brito N.A., Baro D.J., Song C.K., Bartness T.J. Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology 2007, 148:5339-5347.
16. Siegrist-Kaiser C.A., Pauli V., Juge-Aubry C.E., Boss O., Pernin A., Chin W.W., Cusin I., Rohner-Jeanrenaud F., Burger A.G., Zapf J., Meier C.A. Direct effects of leptin on brown and white adipose tissue. J Clin Invest 1997, 100:2858-2864.
17. Brasaemle D.L., Subramanian V., Garcia A., Marcinkiewicz A., Rothenberg A. Perilipin A and the control of triacylglycerol metabolism. Mol Cell Biochem 2009, 326:15-21.
18. Miyoshi H., Souza S.C., Zhang H.H., Strissel K.J., Christoffolete M.A., Kovsan J., Rudich A., Kraemer F.B., Bianco A.C., Obin M.S., Greenberg A.S. Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms. J Biol Chem 2006, 281:15837-15844.
19. Cohen A.W., Razani B., Schubert W., Williams T.M., Wang X.B., Iyengar P., Brasaemle D.L., Scherer P.E., Lisanti M.P. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 2004, 53:1261-1270.
20. Lass A., Zimmermann R., Haemmerle G., Riederer M., Schoiswohl G., Schweiger M., Kienesberger P., Strauss J.G., Gorkiewicz G., Zechner R. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab 2006, 3:309-319.
21. Yang X., Lu X., Lombes M., Rha G.B., Chi Y.I., Guerin T.M., Smart E.J., Liu J. The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab 2010, 11:194-205.
22. Osuga J., Ishibashi S., Oka T., Yagyu H., Tozawa R., Fujimoto A., Shionoiri F., Yahagi N., Kraemer F.B., Tsutsumi O., Yamada N. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci U S A 2000, 97:787-792.
23. Wang S.P., Laurin N., Himms-Hagen J., Rudnicki M.A., Levy E., Robert M.F., Pan L., Oligny L., Mitchell G.A. The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res 2001, 9:119-128.
24. Haemmerle G., Zimmermann R., Strauss J.G., Schoiswohl G., Birner-Gruenberger R., Riederer M., Lass A., Neuberger G., Eisenhaber F., Hermetter A., Zechner R. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004, 306:1383-1386.
25. Ahmadian M., Duncan R.E., Varady K.A., Frasson D., Hellerstein M.K., Birkenfeld A.L., Samuel V.T., Shulman G.I., Wang Y., Kang C., Sul H.S. Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity. Diabetes 2009, 58:855-866.
26. Bezaire V., Mairal A., Ribet C., Lefort C., Girousse A., Jocken J., Laurencikiene J., Anesia R., Rodriguez A.M., Ryden M., et al. Contribution of adipose triglyceride lipase and hormone-sensitive lipase to lipolysis in hMADS adipocytes. J Biol Chem 2009, 284:18282-18291.
27. Langin D., Dicker A., Tavernier G., Hoffstedt J., Mairal A., Ryden M., Arner E., Sicard A., Jenkins C.M., Viguerie N., et al. Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 2005, 54:3190-3197.
28. Steinberg G.R., Kemp B.E., Watt M.J. Adipocyte triglyceride lipase expression in human obesity. Am J Physiol Endocrinol Metab 2007, 293:E958-E964.
29. Schiffelers S.L., Saris W.H., van Baak M.A. The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men. Int J Obes Relat Metab Disord 2001, 25:33-38.
30. Jacobsson H., Bruzelius M., Larsson S.A. Reduction of FDG uptake in brown adipose tissue by propranolol. Eur J Nucl Med Mol Imaging 2005, 32:1130.
31. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., Taittonen M., Laine J., Savisto N.J., Enerback S., Nuutila P. Functional brown adipose tissue in healthy adults. N Engl J Med 2009, 360:1518-1525.
32. van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., Schrauwen P., Teule G.J. Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009, 360:1500-1508.
33. Zingaretti M.C., Crosta F., Vitali A., Guerrieri M., Frontini A., Cannon B., Nedergaard J., Cinti S. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J 2009, 23:3113-3120.
34. Lowell B.B., Susulic V.S., Hamann A., Lawitts J.A., Himms-Hagen J., Boyer B.B., Kozak L.P., Flier J.S. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993, 366:740-742.
35. Feldmann H.M., Golozoubova V., Cannon B., Nedergaard J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab 2009, 9:203-209.
36. Zhou Z., Yon Toh S., Chen Z., Guo K., Ng C.P., Ponniah S., Lin S.C., Hong W., Li P. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet 2003, 35:49-56.
37. Pan D., Fujimoto M., Lopes A., Wang Y.X. Twist-1 is a PPARdelta-inducible, negative-feedback regulator of PGC-1alpha in brown fat metabolism. Cell 2009, 137:73-86.
38. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., Kuo F.C., Palmer E.L., Tseng Y.H., Doria A., et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009, 360:1509-1517.
39. Saito M., Okamatsu-Ogura Y., Matsushita M., Watanabe K., Yoneshiro T., Nio-Kobayashi J., Iwanaga T., Miyagawa M., Kameya T., Nakada K., et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 2009, 58:1526-1531.
40. Scime A., Grenier G., Huh M.S., Gillespie M.A., Bevilacqua L., Harper M.E., Rudnicki M.A. Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha. Cell Metab 2005, 2:283-295.
41. Cederberg A., Gronning L.M., Ahren B., Tasken K., Carlsson P., Enerback S. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 2001, 106:563-573.
42. Polak P., Cybulski N., Feige J.N., Auwerx J., Ruegg M.A., Hall M.N. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 2008, 8:399-410.
43. Singh R., Xiang Y., Wang Y., Baikati K., Cuervo A.M., Luu Y.K., Tang Y., Pessin J.E., Schwartz G.J., Czaja M.J. Autophagy regulates adipose mass and differentiation in mice. J Clin Invest 2009, 119:3329-3339.
44. Pospisilik J.A., Schramek D., Schnidar H., Cronin S.J., Nehme N.T., Zhang X., Knauf C., Cani P.D., Aumayr K., Todoric J., et al. Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell 2010, 140:148-160.
45. Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., Tanaka K., Cuervo A.M., Czaja M.J. Autophagy regulates lipid metabolism. Nature 2009, 458:1131-1135.
46. Rubinsztein D.C., Gestwicki J.E., Murphy L.O., Klionsky D.J. Potential therapeutic applications of autophagy. Nat Rev Drug Discov 2007, 6:304-312.
47. Chakrabarti P., English T., Shi J., Smas C.M., Kandror K.V. Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes 2010, 59:775-781.
48. Rovira J., Marcelo Arellano E., Burke J.T., Brault Y., Moya-Rull D., Banon-Maneus E., Ramirez-Bajo M.J., Gutierrez-Dalmau A., Revuelta I., Quintana L.F., et al. Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients. Transpl Int 2008, 21:992-998.
49. Arch J.R. The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol 2008, 378:225-240.
50. Franco C., Brandberg J., Lonn L., Andersson B., Bengtsson B.A., Johannsson G. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J Clin Endocrinol Metab 2005, 90:1466-1474.
51. Birkenfeld A.L., Budziarek P., Boschmann M., Moro C., Adams F., Franke G., Berlan M., Marques M.A., Sweep F.C., Luft F.C., et al. Atrial natriuretic peptide induces postprandial lipid oxidation in humans. Diabetes 2008, 57:3199-3204.
52. Sengenes C., Bouloumie A., Hauner H., Berlan M., Busse R., Lafontan M., Galitzky J. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 2003, 278:48617-48626.
53. Morisset A.S., Huot C., Legare D., Tchernof A. Circulating IL-6 concentrations and abdominal adipocyte isoproterenol-stimulated lipolysis in women. Obesity (Silver Spring) 2008, 16:1487-1492.
54. Plomgaard P., Fischer C.P., Ibfelt T., Pedersen B.K., van Hall G. Tumor necrosis factor-alpha modulates human in vivo lipolysis. J Clin Endocrinol Metab 2008, 93:543-549.